Marek Malecki1, Mark Anderson2, Michael Beauchaine3, Songwon Seo4, Xenia Tombokan5, Raf Malecki6. 1. University of Wisconsin, Madison, WI, USA ; Phoenix Biomolecular Engineering Foundation, San Francisco, CA, USA. 2. University of Wisconsin, Madison, WI, USA ; National Institutes of Health, National Nuclear Magnetic Resonance Facility, Madison, WI, USA. 3. Bruker AXS, Fitchburg, WI, USA. 4. University of Wisconsin, Madison, WI, USA. 5. Bruker Optics, Dallas, TX, USA. 6. San Francisco State University, San Francisco, CA, USA.
Abstract
INTRODUCTION: Embryonal carcinoma of the ovary (ECO), pure or admixed to other tumors, is the deadly gynecological cancer. SPECIFIC AIM: The specific aim of this work was identification, isolation, clonal expansion, and molecular profiling of the pluripotent cells in the embryonal carcinomas of the ovaries. PATIENTS METHODS: The samples were acquired from the patients, who were clinically and histopathologically diagnosed with the advanced, pure embryonal carcinomas of the ovaries. The cell surface display of the TRA-1-60 and SSEA-4 was analyzed by flow cytometry (FCM), immunoblotting (IB), multiphoton fluorescence spectroscopy (MPFS), nuclear magnetic resonance spectroscopy (NMRS), and total reflection x-ray spectroscopy (TRXFS). The transcripts of the Oct4A and Nanog were analyzed by qRTPCR and MPFS and the products by MPFS. The human pluripotent, embryonic stem cells (ESC), human pluripotent, embryonal carcinoma of the testes (ECT), healthy tissues of the ovary (HTO), healthy tissue of testes (HTT), peripheral blood mononuclear cells (PBMC), and bone marrow mononuclear cells (BMMC) served as the controls. RESULTS: The studied embryonal carcinomas of the ovaries (ECOs) contained the cells with the strong surface display of the TRA-1-60 and SSEA-4, which was similar to the pluripotent ESC and ECT. Their morphology was consistent with the histopathological diagnosis. Moreover, these cells showed strong expression of the Oct4A and Nanog, which was similar to the pluripotent ESC and ECT. The ECO cells formed embryoid bodies, which differentiated into ectoderm, mesoderm, and endoderm. These cells were induced to differentiate into muscles, epithelia, and neurons. CONCLUSION: Herein, we revealed presence and identified molecular profiles of the clones of the pluripotent stem cells in the embryonal carcinomas of the ovaries. These results should help us with refining molecular diagnoses of these deadly neoplasms and design biomarker-targeted, patient-centered, personalized therapy.
INTRODUCTION: Embryonal carcinoma of the ovary (ECO), pure or admixed to other tumors, is the deadly gynecological cancer. SPECIFIC AIM: The specific aim of this work was identification, isolation, clonal expansion, and molecular profiling of the pluripotent cells in the embryonal carcinomas of the ovaries. PATIENTS METHODS: The samples were acquired from the patients, who were clinically and histopathologically diagnosed with the advanced, pure embryonal carcinomas of the ovaries. The cell surface display of the TRA-1-60 and SSEA-4 was analyzed by flow cytometry (FCM), immunoblotting (IB), multiphoton fluorescence spectroscopy (MPFS), nuclear magnetic resonance spectroscopy (NMRS), and total reflection x-ray spectroscopy (TRXFS). The transcripts of the Oct4A and Nanog were analyzed by qRTPCR and MPFS and the products by MPFS. The human pluripotent, embryonic stem cells (ESC), human pluripotent, embryonal carcinoma of the testes (ECT), healthy tissues of the ovary (HTO), healthy tissue of testes (HTT), peripheral blood mononuclear cells (PBMC), and bone marrow mononuclear cells (BMMC) served as the controls. RESULTS: The studied embryonal carcinomas of the ovaries (ECOs) contained the cells with the strong surface display of the TRA-1-60 and SSEA-4, which was similar to the pluripotent ESC and ECT. Their morphology was consistent with the histopathological diagnosis. Moreover, these cells showed strong expression of the Oct4A and Nanog, which was similar to the pluripotent ESC and ECT. The ECO cells formed embryoid bodies, which differentiated into ectoderm, mesoderm, and endoderm. These cells were induced to differentiate into muscles, epithelia, and neurons. CONCLUSION: Herein, we revealed presence and identified molecular profiles of the clones of the pluripotent stem cells in the embryonal carcinomas of the ovaries. These results should help us with refining molecular diagnoses of these deadly neoplasms and design biomarker-targeted, patient-centered, personalized therapy.
Entities:
Keywords:
Cancer of the ovary; embryonal carcinoma of the ovary; germ cell tumor; pluripotent stem cell; stage specific embryonic antigen 4 (SSEA-4); tumor resistance antigen 1-60 (TRA-1-60); variable fragment antibody
Authors: J Marrink; P W Andrews; P J van Brummen; H J de Jong; D T Sleijfer; H Schraffordt Koops; J W Oosterhuis Journal: Int J Cancer Date: 1991-09-30 Impact factor: 7.396
Authors: A Blythe Ryerson; Christie Eheman; Joseph Burton; Nancy McCall; Don Blackman; Sujha Subramanian; Lisa C Richardson Journal: Obstet Gynecol Date: 2007-05 Impact factor: 7.661
Authors: Kristian Almstrup; Christina E Hoei-Hansen; Ute Wirkner; Jonathon Blake; Christian Schwager; Wilhelm Ansorge; John E Nielsen; Niels E Skakkebaek; Ewa Rajpert-De Meyts; Henrik Leffers Journal: Cancer Res Date: 2004-07-15 Impact factor: 12.701
Authors: Maximilian Diehn; Robert W Cho; Neethan A Lobo; Tomer Kalisky; Mary Jo Dorie; Angela N Kulp; Dalong Qian; Jessica S Lam; Laurie E Ailles; Manzhi Wong; Benzion Joshua; Michael J Kaplan; Irene Wapnir; Frederick M Dirbas; George Somlo; Carlos Garberoglio; Benjamin Paz; Jeannie Shen; Sean K Lau; Stephen R Quake; J Martin Brown; Irving L Weissman; Michael F Clarke Journal: Nature Date: 2009-04-09 Impact factor: 49.962
Authors: Jordan M White; Akhila N Kuda-Wedagedara; Madison N Wicker; Daniel E Spratt; William M Schopperle; Elisabeth Heath; Nerissa T Viola Journal: Mol Pharm Date: 2020-02-28 Impact factor: 4.939
Authors: Sigrid Marie Kraggerud; Christina E Hoei-Hansen; Sharmini Alagaratnam; Rolf I Skotheim; Vera M Abeler; Ewa Rajpert-De Meyts; Ragnhild A Lothe Journal: Endocr Rev Date: 2013-04-10 Impact factor: 19.871